Stocktoria
NU SKIN ENTERPRISES, INC. NUS
NYSE · XNYS · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries · website · IPO 1996-11-22
NU SKIN ENTERPRISES, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 69.4% | 68.2% | 68.9% | 71.7% | 75.0% |
| Operating margin | 4.4% | -8.8% | 2.5% | 5.0% | 8.7% |
| Net margin | 10.8% | -8.5% | 0.4% | 4.7% | 5.5% |
| FCF margin | 3.1% | 4.1% | 3.1% | 2.2% | 2.7% |
| Return on assets | 11.4% | -10.0% | 0.5% | 5.8% | 7.7% |
| Return on equity | 19.9% | -22.5% | 1.0% | 11.7% | 16.1% |
| Debt / equity | 0.25× | 0.56× | 0.58× | 0.42× | 0.29× |
| Current ratio | 2.08 | 1.82 | 2.13 | 2.12 | 1.65 |
| Revenue growth | -14.3% | -12.0% | -11.5% | -17.4% | 4.4% |
Source: SEC EDGAR filings · CIK 0001021561 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.